Showing results (171-180 of 672) with videos related to
Sort By:
Pageof 68
Current Opinion in Critical Care|August 29, 2023
Severe infections caused by difficult-to-treat Gram-negative bacteriaSilvia Dettori, Federica Portunato, Antonio Vena, et al.Current Opinion in Infectious Diseases|October 17, 2023
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectivesMatteo Bassetti, Nadia Castaldo, Alberto Fantin, et al.Drugs in Context|June 12, 2020
A brief note on randomized controlled trials and compassionate/off-label use of drugs in the early phases of the COVID-19 pandemicMatteo Bassetti, Paolo Pelosi, Chiara Robba, et al.Expert Review of Anti-Infective Therapy|October 7, 2011
Will new antimicrobials overcome resistance among Gram-negatives?Matteo Bassetti, Francesca Ginocchio, Małgorzata Mikulska, et al.The New Microbiologica|May 2, 2025
Two-drug regimen with dolutegravir plus lamivudine for HIV treatment in children: a narrative reviewClaudia Bartalucci, Laura Labate, Lucia Taramasso, et al.Diagnostic Microbiology and Infectious Disease|March 26, 2019
Antimicrobial treatment challenges in the era of carbapenem resistanceAnna Maria Peri, Yohei Doi, Brian A Potoski, et al.Antibiotics (Basel, Switzerland)|October 27, 2022
Fidaxomicin for the Treatment of <i>Clostridioides difficile</i> Infection in Adult Patients: An Update on Results from Randomized Controlled TrialsDaniele Roberto Giacobbe, Antonio Vena, Marco Falcone, et al.Advances in Therapy|May 18, 2019
Efficacy and Safety of Meropenem-Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc AnalysisMatteo Bassetti, Daniele Roberto Giacobbe, Niki Patel, et al.Intensive Care Medicine|November 9, 2019
Post-operative abdominal infections: epidemiology, operational definitions, and outcomesMatteo Bassetti, Christian Eckmann, Daniele Roberto Giacobbe, et al.Expert Opinion on Pharmacotherapy|September 11, 2020
Therapeutic options for difficult-to-treat A<i>cinetobacter baumannii</i> infections: a 2020 perspectiveMatteo Bassetti, Laura Labate, Chiara Russo, et al.Pageof 68